[HTML][HTML] Synthetic biology goes cell-free
A Tinafar, K Jaenes, K Pardee - BMC biology, 2019 - Springer
Cell-free systems (CFS) have recently evolved into key platforms for synthetic biology
applications. Many synthetic biology tools have traditionally relied on cell-based systems …
applications. Many synthetic biology tools have traditionally relied on cell-based systems …
[HTML][HTML] Current status of nanomaterial-based treatment for hepatocellular carcinoma
Cancer continues to be the leading cause of death worldwide. Hepatocellular carcinoma
(HCC), a prominent form of liver cancer, is the second leading cause of cancer-related …
(HCC), a prominent form of liver cancer, is the second leading cause of cancer-related …
An ecofriendly synthesized gold nanoparticles induces cytotoxicity via apoptosis in HepG2 cells
JT Nandhini, D Ezhilarasan… - Environmental …, 2021 - Wiley Online Library
Microbes have long been used for the synthesis of a variety of nanoparticles. Hepatocellular
carcinoma (HCC) is the primary liver cancer and it is the second leading cause of cancer …
carcinoma (HCC) is the primary liver cancer and it is the second leading cause of cancer …
[HTML][HTML] Tryptophan-sorbitol based carbon quantum dots for theranostics against hepatocellular carcinoma
Y Wang, J Chen, J Tian, G Wang, W Luo… - Journal of …, 2022 - Springer
Background Despite novel advances in screening, targeting and immunotherapies, early
diagnosis and satisfactory treatments against hepatocellular carcinoma (HCC) remain …
diagnosis and satisfactory treatments against hepatocellular carcinoma (HCC) remain …
[HTML][HTML] A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1)
Z Zhang, J Zhang, J Tian, H Li - Journal of nanobiotechnology, 2021 - Springer
Knocking down the oncogene ROC1 with siRNA inhibits the proliferation of cancer cells by
suppressing the Neddylation pathway. However, methods for delivering siRNA in vivo to …
suppressing the Neddylation pathway. However, methods for delivering siRNA in vivo to …
Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma
MH Elnaggar, AI Abushouk, AHE Hassan… - Seminars in cancer …, 2021 - Elsevier
The effectiveness of chemotherapy in hepatocellular carcinoma (HCC) is restricted by
chemo-resistance and systemic side effects. To improve the efficacy and safety of …
chemo-resistance and systemic side effects. To improve the efficacy and safety of …
Recent advances in nanotechnology-based targeted therapeutics for breast cancer management
A Alhalmi, S Beg, WH Almalki… - Current Drug …, 2022 - ingentaconnect.com
Despite the great efforts that have been achieved in breast cancer treatment, it remains a
significant cause of death in women and is a serious health problem. Treatment with …
significant cause of death in women and is a serious health problem. Treatment with …
Biogenic silver nanoparticle synthesis and stabilization for apoptotic activity; insights from experimental and theoretical studies
Synthesis of nanoparticles (NPs) from common food waste is an eco-friendly and cost-
effective method. The present communication reports one-pot biosynthesis of silver …
effective method. The present communication reports one-pot biosynthesis of silver …
Recent advances in bionanomaterials for liver cancer diagnosis and treatment
MMH Chowdhury, CJJ Salazar, M Nurunnabi - Biomaterials science, 2021 - pubs.rsc.org
According to the World Health Organization, liver cancer is the fourth leading cause of
cancer associated with death worldwide. It demands effective treatment and diagnostic …
cancer associated with death worldwide. It demands effective treatment and diagnostic …
[HTML][HTML] Liver cancer: current and future trends using biomaterials
Hepatocellular carcinoma (HCC) is the fifth most common type of cancer diagnosed and the
second leading cause of death worldwide. Despite advancement in current treatments for …
second leading cause of death worldwide. Despite advancement in current treatments for …